ArticleTrials2020

Prevention of doxorubicin-induced Cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on Docosahexaenoic Acid (DHA) and carvedilol direct antioxidant effects: study protocol for a pilot, randomized, double-blind, controlled trial (CarDHA trial).

Rodrigo Carrasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.